Vanberra Signal

OvaScience

Curated by Signal

Developer of new fertility treatments for women

Overview

Developer of new fertility treatments for women. The treatment is based on its proprietary technology platform that leverages the discovery of egg precursor (EggPC) cells – immature egg cells found inside the protective ovarian lining. The AUGMENT treatment, a fertility option specifically designed to improve egg health, is available in certain IVF clinics in select international regions. Also has OvaPrime program, which could increase a woman’s egg reserve, and is developing the OvaTure treatment, an IVF treatment that could help a woman produce healthy, young, fertilizable eggs without hormone injections. OvaScience treatments are not available in the U.S.

Key facts

Founded
2011

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of health monitoring devices for providers

    Life Sciences TechnologyPalo Alto, United States
  • Provider of an integrative platform for genome analysis using AI

    Life Sciences TechnologyNewark, United States
  • Surgical planning solutions for medical & educational purposes

    Life Sciences TechnologySan Jose, United States

About OvaScience

What does OvaScience do?

Developer of new fertility treatments for women.

Where is OvaScience headquartered?

OvaScience is headquartered in Waltham, United States.

When was OvaScience founded?

OvaScience was founded in 2011.

Which sector is OvaScience in?

OvaScience operates in Life Sciences Technology.

Who are OvaScience's competitors?

Companies similar to OvaScience include ATOM Health, GenPro, and Anatomage.